Yeon Sook Choi

Director, In Vivo Pharmacology at Kestrel Therapeutics

Role
Director at Kestrel Therapeutics
Location
Boston, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Yeon Sook Choi

Focus on discovery of drug candidates and evaluation of effects of therapeutic candidates for human diseases and cancers.• Industrial and academic experience with diverse in vivo models of oncology, targeted small molecule-focused drug discovery programs and platform, anti-tumor immuno-therapeutics, and development of preclinical murine models mimicking human diseases.• Experience in building up new in vivo pharmacology team from the ground and establishing operational objectives, procedures, and comprehensive in vivo strategic plans to evaluate in vivo efficacies.• Extensive understanding of PK/PD/efficacy assessments and preclinical data package generation to help support human dose prediction, and efficiently leading and mentoring a high-functioning in vivo pharmacology team contributing to drug portfolio through timely professional in vivo efforts.• Ability to communicate clearly in vivo strategy to internal and external stakeholders and collaborate effectively with multidisciplinary preclinical discovery teams (Biology, DMPK, Drug Safety/Toxicology, Formulation, Translational medicine, Bioinformatics, and Chemistry) in order to move preclinical drug discovery programs forward to clinical trials.• Comprehensive experience of diverse in vivo models including human cell line-derived xenografts (CDX), patient-derived xenografts (PDX), syngeneic rodent cancer models, and genetically engineered mouse (GEM) models. • Proficiency and hands-on experience with the in-life procedures and techniques including diverse routes (PO, IP, IV, SC, iTu) of drug administration, tumor growth monitoring, IVIS, rodent clinical observation, necropsy, and blood/tissue sample collections.• Manage numerous time-sensitive internal and external in vivo pharmacology studies, and have strong experience with IACUC protocol writing, interaction with IACUC, and internal vivarium management and operations.• Working experience as a Director in vivo pharmacology at small molecule/mRNA/oncolytic virus modalities-leveraged biotech in Great Boston area.• Ph.D. degree in Life Science/Biotechnology and postdoctoral background in oncology and cell biology, mouse modeling and genetics, molecular and developmental biology, biochemistry, dermatology, and immunology-oncology.

Experience

  1. Director

    Kestrel Therapeutics

    May 2024 — Present

Education

  • Korea University

    Ph.D., Life Science/Biotechnology

    1998 — 2002

Skills

  • Gel Extraction
  • Confocal Microscopy
  • Skin Cancer and Disease
  • Immunohistochemistry
  • Rt-Pcr
  • In Situ Hybridization
  • Microscopy
  • Rna Isolation
  • Immunofluorescence
  • Histopathology
  • Cell Based Assays
  • Dna Extraction
  • Molecular & Cellular Biology
  • Molecular Genetics
  • Celltiter-Glo
  • H&E Staining
  • Immunoprecipitation
  • Cryostat
  • Transfection
  • Cryosectioning
  • Dna Replication
  • Pcr Primer Design
  • Tissue Processing
  • Immunocytochemistry
  • Facs Analysis
  • Southern Blot
  • Chip
  • Pcr
  • Primary Cell Isolation
  • Recombinant Dna
  • In Vivo and in Vitro Drug Screening
  • Vector Cloning
  • Elisa
  • Co-Ip
  • Mouse Models
  • Dna Electrophoresis
  • Fluorescence Microscopy
  • Northern Blotting
  • Reporter Gene Assays
  • Qrt-Pcr

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Yeon Sook Choi — Director at Kestrel Therapeutics in Boston, MA, US | Unifers